[Preventing chronicity in mental health: being present earlier within the network]. / Voorkómen chroniciteit: er eerder bij zijn binnen het netwerk.

BACKGROUND: Despite the increase in treatment options, mental illness is still too often evolving into chronic serious mental illness.
AIM: To describe concrete interventions aimed at the life structure and early detection within and outside mental health care to prevent chronicity in mental health.
METHOD: According to a quadrant, evidence-based interventions to prevent chronicity are proposed. These interventions can focus on the life structure of the patient and on early identification and intervention. They can take place both inside and outside mental health care.
RESULTS: Important interventions within mental health care include complete and repeated diagnostics, including staging, profiling and somatic screening, Mental health care must also focus on early detection and early treatment for all mental illnesses and apply concrete interventions such as IPS, lifestyle interventions, shared decision-making and low threshold anti-stigma actions. Outside of mental health services, mental health first aid (MHFA), housing first, alcohol prevention and mental gymnastics can be used.
CONCLUSION: Preventing chronicity requires an integrated cross-sectoral approach and a gatekeeper approach with active and responsive mental health care. Tijdschrift voor Psychiatrie 63(2021)2, 142-149.

[Using resource groups in assertive community treatment; literature review and recommendation]. / De inzet van resourcegroepen voor gedeelde besluitvorming bij assertive community treatment; literatuuroverzicht en aanbevelingen.

BACKGROUND: In psychiatry there is an increasing interest in giving patients and their relatives control over the goals of treatment and the way in which treatment is carried out. A structural method of organising this within assertive community treatment (ACT) is to let patients and their relatives participate in what is known as a resource group (RG).
AIM: To provide a systematic view of the advantages of giving patients control over their treatment and the way in which it is carried out via ACT, particularly if this control is organised in the form of an RG.
METHOD: We reviewed the relevant literature on the basis of search instructions in the databases of PubMed and Cochrane Library. We found nine trials that had a randomised controlled design (RCT). Only one of these RCTs involved the use of an RG in ACT.
RESULTS: The approaches used in ACT, whereby patients with schizophrenia had control over their treatment, led to significant improvements that were considerably greater than those achieved in standard care. Improvements were found in symptomatology, social functioning and in the quality of life. There are indications that treatment satisfaction and social functioning improve still further if patients' control over their treatment is organised in an RG.
CONCLUSION: Research demonstrates that positive results are achieved with ACT whereby patients have control over their treatment and the way in which it is carried out. However, further research is needed to determine whether this addition to ACT in the form of an RG is superior to other approaches used previously in ACT, particularly if it concerns the inclusion of an RG.

[Functional remission of people with serious mental illness (SMI): psychometric properties of a new ROM-instrument]. / Functionele remissie bij mensen met een ernstige psychiatrische aandoening; psychometrische eigenschappen van een nieuw ROM-instrument.

BACKGROUND: Instruments are used for routine outcome monitoring of patients with severe mental illness in order to measure psychiatric symptoms, care needs and quality of life. By adding an instrument for measuring functional remission a more complete picture can be given of the complaints, the symptoms and general functioning, which can give direction to providing care for patients with severe mental illness. AIM: To describe the development and testing of a new instrument of functional remission (FR) among people with a psychotic disorder or another serious mental disorder (SMI) as an addition to the symptomatic remission (SR), according to international criteria. METHOD: The FR-assessment involves assessment by a mental health professional who conducts a semi-structured interview with the patient and his or her family and/or uses patient files relating to the three areas of functioning: daily living and self-care; work, study and housekeeping; and social contacts. These areas are rated on a three-point scale of 0: independent; 1: partially independent; 2: dependent. The assessment covers a period of six months, in accordance with the measurement of symptomatic remission and should be part of regular routine outcome monitoring (ROM) procedures. The FR-instrument was used in 2012 with 840 patients from eight Dutch mental care institutions and included a one-year follow-up among 523 patients (response 62%). RESULTS: The results showed that the instrument is relatively easily to complete. It was also relevant for clinical practice, although further research is needed because of the raters' low response. Intra- and inter-rater reliability, discriminating and convergent validity, and sensitivity to change were rated sufficient to good. CONCLUSION: If the FR-instrument becomes part of regular ROM-procedures and is used as a measure of societal participation, it could be a useful addition to current measures of symptomatic remission.

[Delirium on re-starting clozapine after a short break in treatment]. / Delirium bij herstart clozapine na korte onderbreking.

Extra care must be taken in treating patients with clozapine because of the serious side-effects. A 44-year-old man with schizophrenia developed delirium on two occasions immediately after restarting clozapine at the dosage he had previously tolerated well; the clozapine-free periods had lasted 2 and 10 days respectively. Because of this 're-challenge' it seems very likely that there is a causal relation between the direct resumption of treatment with clozapine and delirium. Even if clozapine treatment is interrupted for only a short time it is important that the 'new' course begins with a low dosage and is increased very cautiously until it reaches the former, tolerated level.